共 46 条
- [21] Assessing Quality of Life Using FHIR How to Combine Patient Reported Outcome with Patient Generated Data for Better Compliance [J]. CARING IS SHARING-EXPLOITING THE VALUE IN DATA FOR HEALTH AND INNOVATION-PROCEEDINGS OF MIE 2023, 2023, 302 : 135 - 136
- [25] Is poor quality non-melanoma skin cancer data affecting high quality research and patient care? [J]. JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY, 2021, 74 (06): : 1367 - 1368
- [27] Interdisciplinary Cooperation despite non-Compliance: The Result of exceptional interdisciplinary Teamwork across several Fields of Cardiology, although the Patient himself does not contribute to the Success of the Therapy and therefore cannot be listed for an HTX [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 2) : 162 - 163
- [29] Issues with missing data in trials of complex interventions: Using therapy non-compliance, we demonstrate a framework for assessing how to deal with the potential bias caused by missing data, a systematic way of determining which pre-/post-randomisation variables predict missingness in final outcomes and assess the need for multiple imputation [J]. TRIALS, 2019, 20
- [30] Are the data on quality of life and patient reported outcomes from clinical trials of metastatic non-small-cell lung cancer important? [J]. WORLD JOURNAL OF CLINICAL ONCOLOGY, 2013, 4 (04): : 82 - 84